Company / R&D per Share
TENAX THERAPEUTICS, INC. R&D per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.72
FY2025
5-year range
$0.11 / $10.83
FY2021-FY2025
Trend
-65.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $0.11 in FY2016 to $10.83 in FY2024.
Based on SEC 10-K filings.
3.72 in FY2025 with a 10-year CAGR of +42.5%.
Improved from $0.11 to $3.72 over the past 9 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +42.5%
Key checks
Key Insights
- In FY2025, r&d per share decreased 65.7% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.72 | -65.7% |
| FY2024 | $10.83 | +10058.0% |
| FY2016 | $0.11 | -0.9% |
| FY2015 | $0.11 | -91.5% |
| FY2014 | $1.27 | -24.0% |
| FY2013 | $1.67 | +1360.5% |
| FY2012 | $0.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026